156 related articles for article (PubMed ID: 16580726)
1. Paradoxical discrepancy between the serum level and the placental intensity of PP5/TFPI-2 in preeclampsia and/or intrauterine growth restriction: possible interaction and correlation with glypican-3 hold the key.
Ogawa M; Yanoma S; Nagashima Y; Okamoto N; Ishikawa H; Haruki A; Miyagi E; Takahashi T; Hirahara F; Miyagi Y
Placenta; 2007; 28(2-3):224-32. PubMed ID: 16580726
[TBL] [Abstract][Full Text] [Related]
2. Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts.
Udagawa K; Yasumitsu H; Esaki M; Sawada H; Nagashima Y; Aoki I; Jin M; Miyagi E; Nakazawa T; Hirahara F; Miyazaki K; Miyagi Y
Placenta; 2002; 23(2-3):145-53. PubMed ID: 11945080
[TBL] [Abstract][Full Text] [Related]
3. Increased placental expression of Placental Protein 5 (PP5) / Tissue Factor Pathway Inhibitor-2 (TFPI-2) in women with preeclampsia and HELLP syndrome: Relevance to impaired trophoblast invasion?
Karaszi K; Szabo S; Juhasz K; Kiraly P; Kocsis-Deak B; Hargitai B; Krenacs T; Hupuczi P; Erez O; Papp Z; Kovalszky I; Than NG
Placenta; 2019 Jan; 76():30-39. PubMed ID: 30803712
[TBL] [Abstract][Full Text] [Related]
4. Changes of plasma and placental tissue factor pathway inhibitor-2 in women with preeclampsia and normal pregnancy.
Xiong Y; Zhou Q; Jiang F; Zhou S; Lou Y; Guo Q; Liang W; Kong D; Ma D; Li X
Thromb Res; 2010 Jun; 125(6):e317-22. PubMed ID: 20347477
[TBL] [Abstract][Full Text] [Related]
5. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.
Chafetz I; Kuhnreich I; Sammar M; Tal Y; Gibor Y; Meiri H; Cuckle H; Wolf M
Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748
[TBL] [Abstract][Full Text] [Related]
6. Placental localization and expression of the cell death factors BNip3 and Nix in preeclampsia, intrauterine growth retardation and HELLP syndrome.
Stepan H; Leo C; Purz S; Höckel M; Horn LC
Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):172-6. PubMed ID: 16219518
[TBL] [Abstract][Full Text] [Related]
7. Maternal serum levels of placental protein 5 in complications of late pregnancy.
Salem HT; Westergaard JG; Hindersson P; Lee JN; Grudzinskas JG; Chard T
Obstet Gynecol; 1982 Apr; 59(4):467-71. PubMed ID: 7078900
[TBL] [Abstract][Full Text] [Related]
8. The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients.
Teng Y; Jiang R; Lin Q; Ding C; Ye Z
Thromb Res; 2010 Jul; 126(1):e41-5. PubMed ID: 20226500
[TBL] [Abstract][Full Text] [Related]
9. Placental expression of syndecan 1 is diminished in preeclampsia.
Jokimaa VI; Kujari HP; Ekholm EM; Inki PL; Anttila L
Am J Obstet Gynecol; 2000 Dec; 183(6):1495-8. PubMed ID: 11120517
[TBL] [Abstract][Full Text] [Related]
10. Assessing the role of placental trisomy in preeclampsia and intrauterine growth restriction.
Robinson WP; Peñaherrera MS; Jiang R; Avila L; Sloan J; McFadden DE; Langlois S; von Dadelszen P
Prenat Diagn; 2010 Jan; 30(1):1-8. PubMed ID: 19918961
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of maternal and umbilical serum TNFalpha levels in preeclamptic pregnancies in the intrauterine normal and growth-restricted fetus.
Laskowska M; Leszczyńska-Gorzelak B; Laskowska K; Oleszczuk J
J Matern Fetal Neonatal Med; 2006 Jun; 19(6):347-51. PubMed ID: 16801311
[TBL] [Abstract][Full Text] [Related]
12. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia.
Schjetlein R; Abdelnoor M; Haugen G; Husby H; Sandset PM; Wisløff F
Acta Obstet Gynecol Scand; 1999 Mar; 78(3):191-7. PubMed ID: 10078579
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of two serine protease HtrA1 forms in human placentas complicated by preeclampsia with and without intrauterine growth restriction.
Lorenzi T; Marzioni D; Giannubilo S; Quaranta A; Crescimanno C; De Luca A; Baldi A; Todros T; Tranquilli AL; Castellucci M
Placenta; 2009 Jan; 30(1):35-40. PubMed ID: 19056122
[TBL] [Abstract][Full Text] [Related]
14. Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: a multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension.
Scioscia M; Paine MA; Gumaa K; Rodeck CH; Rademacher TW
J Matern Fetal Neonatal Med; 2008 Aug; 21(8):581-5. PubMed ID: 18609357
[TBL] [Abstract][Full Text] [Related]
15. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction.
Cetin I; Cozzi V; Pasqualini F; Nebuloni M; Garlanda C; Vago L; Pardi G; Mantovani A
Am J Obstet Gynecol; 2006 May; 194(5):1347-53. PubMed ID: 16647920
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor, its receptors, and the tie receptors in the placental bed of women with preeclampsia, diabetes, and intrauterine growth retardation.
Vuorela P; Halmesmäki E
Am J Perinatol; 2006 May; 23(4):255-63. PubMed ID: 16625496
[TBL] [Abstract][Full Text] [Related]
17. Expression of serine proteinase inhibitor PP5/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo.
Jin M; Udagawa K; Miyagi E; Nakazawa T; Hirahara F; Yasumitsu H; Miyazaki K; Nagashima Y; Aoki I; Miyagi Y
Gynecol Oncol; 2001 Nov; 83(2):325-33. PubMed ID: 11606093
[TBL] [Abstract][Full Text] [Related]
18. Short telomeres may play a role in placental dysfunction in preeclampsia and intrauterine growth restriction.
Biron-Shental T; Sukenik-Halevy R; Sharon Y; Goldberg-Bittman L; Kidron D; Fejgin MD; Amiel A
Am J Obstet Gynecol; 2010 Apr; 202(4):381.e1-7. PubMed ID: 20350645
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of N-myc downstream-regulated gene 1 (NDRG1) in placentas from pregnancies complicated by intrauterine growth restriction or preeclampsia.
Choi SJ; Oh SY; Kim JH; Sadovsky Y; Roh CR
Am J Obstet Gynecol; 2007 Jan; 196(1):45.e1-7. PubMed ID: 17240229
[TBL] [Abstract][Full Text] [Related]
20. Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas.
Jeschke U; Mayr D; Schiessl B; Mylonas I; Schulze S; Kuhn C; Friese K; Walzel H
Placenta; 2007; 28(11-12):1165-73. PubMed ID: 17664004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
